Stability of blood coagulation factors and inhibitors in blood drawn into half-strength citrate anticoagulant.
Drawing of blood into a citrate-phosphate-dextrose (CPD) solution with a reduced citrate concentration has been shown to improve the maintenance of coagulation factor VIII (F VIII) in plasma and to give possibilities to improve erythrocyte preservation. We studied the quality of plasma obtained from whole blood drawn under continuous mixing into CPD in which the citrate concentration was reduced by 50% (0.5CPD). The blood was stored at room temperature for 8 h before component preparation. We confirmed improved stability of F VIII by 0.5CPD. We found no clinically significant changes in inhibitors to the coagulation and kallikrein systems, and no signs of activation of these systems, during the 8-hour holding time. In control blood drawn into CPD, F VIII and coagulation factor IX decreased by 0.09 IU/ml (8%) and 0.07 U/ml (7%), respectively, otherwise we found no significant differences between 0.5CPD plasma and CPD plasma.
Suontaka
A M
AM
Department of Laboratory Medicine/Blood Coagulation Research, Karolinska Hospital, Stockholm, Sweden.
Akerblom
O
O
Blombäck
M
M
Eriksson
L
L
Högman
C F
CF
Payrat
J M
JM
D000925:Anticoagulants; D001779:Blood Coagulation Factors / Q000032:analysis*; D001793:Blood Preservation / Q000379:methods*; D002951:Citrates; D006801:Humans
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D002951:Citrates